;

Auto Summaries - Symptoms
Last updated: 2021 Sep 7
Total hit(s): 2013
S.No.
1
33583290
Clinical outcomes of initially asymptomatic patients with COVID-19: a Korean nationwide cohort study
Identify risk factors associated with high patient mortality.Determine the mortality rate and admission rate to intensive care unit (ICU).Consider the age-adjusted Charlson comorbidity index score (CCIS).
Ann Med
2021 Dec
3.01
1
2
34312589
Variations by race/ethnicity and time in Covid-19 testing among Veterans Health Administration users with COVID-19 symptoms or exposure
Racial/ethnic disparities in coronavirus disease 2019 (COVID-19) hospitalization and mortality have emerged in the United States. We examined racial/ethnic variations in testing over time among veterans who sought care for symptoms or exposure. The United States faced testing shortages at the start of the third wave of the pandemic.
Prev Med Rep
2021 Dec
3.8
1
3
34333175
The network of stress-related states and depression and anxiety symptoms during the COVID-19 lockdown
The coronavirus (COVID-19) pandemic and social distancing protocols used to impede the spread of the virus may have severe mental health consequences. Some components of the pandemic-related distressing states of fear of infection, financial worry and loneliness seem to be associated with specific symptoms of MDD and GAD.
J Affect Disord
2021 Nov 1
4.17
1
4
34343929
Network analysis of physical and psychiatric symptoms of hospital discharged patients infected with COVID-19
In the current study, we aimed to investigate the network structure of COVID-19 symptoms and its related psychiatric symptoms using a network approach. We highlighted potential pathways between severity and psychiatric symptoms. Specific pathways were discussed. Finally, we used directed acyclic graph estimation to show potential causal effects between COV-19 related variables and demographic characteristics.
J Affect Disord
2021 Nov 1
4.17
1
5
34375206
Longitudinal associations between internalizing symptoms, social behavior, and social perceptions in the initial months of the COVID-19 pandemic: Findings from a transdiagnostic community sample
Loneliness during the COVID-19 pandemic is tied to high levels of depression and anxiety. People who struggle with depression and anhedonia were particularly vulnerable to distressing feelings of social disconnection amid the pandemic. Study: Social behavior and social perceptions were dissociable.
J Affect Disord
2021 Nov 1
4.17
1
6
34375200
Network analysis of anxiety and depressive symptoms among nursing students during the COVID-19 pandemic
The 2019 coronavirus disease (COVID-19) pandemic has impacted the mental health and well-being of medical personnel, including nursing students. The aim of this study was to elucidate characteristics of anxiety and depressive symptom networks of Chinese nursing students during the COVE-19 pandemic. Irritability, Uncontrollable worry, Trouble relaxing, and Depressed mood had the highest centrality values. Three bridge symptoms (Depressed mood, Nervousness, and Anhedonia) were also identified. Neither gender nor region of residence was associated with network global strength, distribution of edge weights or individual edge weights.
J Affect Disord
2021 Nov 1
4.17
1
7
34377750
Dynamic functional network connectivity associated with post-traumatic stress symptoms in COVID-19 survivors
Coronavirus Disease 19 (COVID-19) survivors may encounter prolonged mental issues, especially post-traumatic stress symptoms (PTSS) Despite manifesting a plethora of behavioral or mental issues in these survivors, previous studies illustrated that static brain functional networks of these survivors remain intact.
Neurobiol Stress
2021 Nov
1
8
34177027
Perceived stress of the COVID-19 pandemic and adolescents' depression symptoms: The moderating role of character strengths
The negative effect of the COVID-19 pandemic on adolescents' mental health might be moderated by their existing psychological resources. A total of 617 adolescents were recruited and completed the online survey during the epidemic. Character strengths as a protective factor could buffer the effect of perceived stress of the co-incidence on their depression symptoms.
Pers Individ Dif
2021 Nov
n/a
1
9
34430677
Neural connectome prospectively encodes the risk of post-traumatic stress disorder (PTSD) symptom during the COVID-19 pandemic
The novel coronavirus (COVID-19) pandemic has affected humans worldwide and led to unprecedented stress and mortality. Detrimental effects of the pandemic on mental health, including risk of post-traumatic stress disorder (PTSD) have become an increasing concern.
Neurobiol Stress
2021 Nov
1
10
34301485
Prospective analytical performance evaluation of the QuickNavi™-COVID19 Ag for asymptomatic individuals
Antigen testing may help screen for and detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in asymptomatic individuals. However, limited data regarding the diagnostic performance of antigen tests for this group are available. We used clinical samples to evaluate the analytical and clinical performance of the antigen test QuickNavi™-COVID19 Ag.
J Infect Chemother
2021 Oct
1.59
2
11
34055580
Comparative retrospective open-label study of ayurvedic medicines and their combination with allopathic drugs on asymptomatic and mildly-symptomatic COVID-19 patients
Understand the potential of Ayurveda.Understand the effects of Allopathic and Ayurvedic medicines on COVID-19 patients.Recognize the symptomatic improvement of allopathic and Ayurvedic medicines.
J Herb Med
2021 Oct
1
12
34458543
Surgical stabilization of rib fractures in symptomatic COVID-19: A case report
Surgical stabilization of rib fractures (SSRF) is increasingly considered to be advantageous in this population. During the coronavirus disease 2019 (COVID-19) pandemic, ventilators have become a scarce resource. We present a report of the perioperative outcome of SSRF in a geriatric polytrauma patient.
Trauma Case Rep
2021 Oct
1
13
34345869
Anxiety, depression, insomnia, and trauma-related symptoms following COVID-19 infection at long-term follow-up
A developing finding from the novel coronavirus 2019 (COVID-19) pandemic is the burden of neuropsychiatric symptoms seen in survivors. While studies have shown clinically significant rates of depression, anxiety, insomnia, and trauma-related symptoms such as post-traumatic stress disorder. Little is known about how these symptoms evolve over time.
Brain Behav Immun Health
2021 Oct
~
1
14
34393019
Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study)
In Estonia, during the first wave of COVID-19 total number of cases confirmed by PCR was 13.3/10,000. In the hotspot of Estonian epidemic, an island Saaremaa, the cumulative incidence was 166.1/10k. Of seropositive subjects 19.2% (14/73) had acute respiratory illness. Fever, diarrhea and absence of cough and runny nose were associated with seropositivity in individuals aged 50 or more years. IgG, but not neutralizing antibodies concentrations were higher if fever, difficulty breathing, shortness of breath, chest pain or diarrhea was present, or hospitalization required. Focusing only on respiratory symptoms may delay accurate diagnosis of SARS-CoV-2 infection.
Vaccine
2021 Sep 7
3.31
1
15
34396083
Distinct lipid metabolic dysregulation in asymptomatic COVID-19
Study provides a potential prediagnostic method for asymptomatic COVID-19 and molecular clues for the pathogenesis and therapy of this disease. The unique lipid metabolic dysregulation was revealed, especially the enhanced synthesis of membrane phospholipids, altered sphingolipidids homeostasis, and differential fatty acids metabolic pattern.
iScience
2021 Sep 24
4.447
1
16
34475190
Perceptions on undertaking regular asymptomatic self-testing for COVID-19 using lateral flow tests: a qualitative study of university students and staff
Participants were motivated to regularly self-test as they wanted to know whether or not they were infected with SARS-CoV-2. Most reported that a negative test result did not change their behaviour, but it did provide them with reassurance to engage with permitted activities. Concerns about safety, convenience of testing and ability to do tests need to be addressed. Clear messages highlighting the benefits of regular testing for family, friends and society in identifying asymptomatic cases are needed.
BMJ Open
2021 Sep 2
2.49
1
17
34473275
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
Remdesivir has shown a significant reduction in the time to recovery in patients with COVID-19. However, the impact on mortality is still controversial and it is necessary to evaluate whether there is a specific subgroup of patients in whom active antiviral therapy also reduces the mortality. Pre-admission symptom duration of 4-6 days and ≤3 days was associated with a 1.5-2-5-fold increase in the mortality rate.
J Antimicrob Chemother
2021 Sep 2
4.94
1
18
34473245
Evolution of COVID-19 symptoms during the first 12 months after illness onset
The RECoVERED Study is a prospective cohort study based in Amsterdam, the Netherlands. Participants aged≥18 years were enrolled following SARS-CoV-2 diagnosis via the local Public Health Service and from hospitals. 99/342(29%) had mild, 145/342 (42%) moderate, 56/342 severe and 42/342 critical disease. At 12 months after illness onset, two-fifths of participants (40.7%[95%CI=34.2-47.1] continued to report ≥1 symptoms. Recovery was slower in female compared to male participants. Female sex and obesity were the most important determinants of speed of recovery from symptoms.
Clin Infect Dis
2021 Sep 2
7.71
1
19
34473217
Symptoms Reported With New Onset of Loss of Taste or Smell in Individuals With and Without SARS-CoV-2 Infection
" Centers for Disease Control and Prevention, Atlanta, Georgia. CDC: ""It's a great place to learn about the effects of this type of disease,"" says Dr. Tom Friedenberger. He says he has been diagnosed with HIV-AIDS in his hometown of Atlanta."
JAMA Otolaryngol Head Neck Surg
2021 Sep 2
6.5
1
20
34468069
Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID-19
Medical records of patients hospitalized with COVID-19 between March 1 and June 30, 2020 were reviewed for the presence of GI symptoms at primary care follow-up 1 to 6 months later. 40% of patients from COVID survivor groups reported new GI symptoms after recovery.
Neurogastroenterol Motil
2021 Sep 1
1
21
34296966
Blunted peripheral but not cerebral vasodilator function in young otherwise healthy adults with persistent symptoms following COVID-19
Study was the first to investigate the persistent effects of COVID-19 on vascular function in otherwise healthy young adults. We demonstrated that peripheral macrovascular and microvascular function was significantly blunted in young adults still symptomatic from COVE-19 beyond the acute phase. In contrast, cerebral vascular function and central arterial stiffness were unaffected.
Am J Physiol Heart Circ Physiol
2021 Sep 1
1
22
34280114
Effect of the Period From COVID-19 Symptom Onset to Confirmation on Disease Duration: Quantitative Analysis of Publicly Available Patient Data
In general, early intervention in disease based on early diagnosis is considered to be very important for improving health outcomes. But there is still insufficient evidence regarding how medical care that is based on the early diagnosis of confirmed cases can affect the outcome of COVID-19 treatment. We collected data from 4002 confirmed cases in 33 cities reported up to May 31, 2020.
J Med Internet Res
2021 Sep 1
5.05
1
23
34388938
Searching for a clinically validated definition of ""asymptomatic"" COVID-19 infection
Section of Clinical Biochemistry at University of Verona in Verona, Italy. The section is based on clinical biochemistry from the University of Verona's Clinamic Biochemistry Department. Inventor has published a number of scientific journals that have been published worldwide.
Int J Clin Pract
2021 Sep
2.62
1
24
34352201
Prevalence and Predictors of Persistence of COVID-19 Symptoms in Older Adults: A Single-Center Study
Symptom persistence weeks after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) clearance is a relatively common long-term complication of Coronavirus disease 2019 (COVID-19) Little is known about this phenomenon in older adults.
J Am Med Dir Assoc
2021 Sep
5.02
1
25
34401225
Dynamics of a stochastic delay differential model for COVID-19 infection with asymptomatic infected and interacting people: Case study in the UAE
Public health science is increasingly focusing on understanding how COVID-19 spreads among humans. We propose a stochastic epidemic model, Susceptible-Infected-Asymptomatic-Quarantined-Recovered (SIAQR) One global positive solution exists with probability one in the model. To estimate the percentages of people who must be vaccinated to achieve herd immunity, least-squares approaches were used to estimate R0 from real observations in the UAE.
Results Phys
2021 Sep
7
1